Global Multiplex Assay Market Forecast 2024-2032

The global multiplex assay market is set to record a CAGR of 8.12% over the forecast period, 2024-2032. The market growth is facilitated by key factors like increased government funding as well as research and development activities, the growing preference for multiplex assays over conventional assays, and the rising adoption of personalized medicines.

MARKET INSIGHTS

A multiplex assay is a procedure in which several analytes, including proteins, cytokines, biomolecules, growth factors, chemokines, and others, are profiled by detecting and quantifying them simultaneously. The assay is utilized to amplify multiple targets in a polymerase chain reaction (PCR) and gather added information from minute quantities of proteins or other analytes in less time compared to traditional methods like ELISA.

Multiplex assays hold tremendous potential in the research and development of drugs for the treatment of diseases such as cancer and cardiovascular diseases. For instance, bead-based Luminex xMAP multiplex assay offers a platform for cancer biomarker assays compatible with plasma, cultured cells, serum, as well as other biological samples. The American Association of Cancer Research (AACR) designed the multiplex immunoassay that assisted in the examination of acquired resistance to receptor tyrosine kinase (RTK) inhibitors. Moreover, RTK is utilized as a target for drug development to treat cancer.

REGIONAL INSIGHTS

The global multiplex assay market growth assessment includes the geographical analysis of North America, Europe, Asia-Pacific, and Rest of World. North America is set to harbor the highest market share by the end of the forecast period. The market growth is attributed to key drivers such as the increasing research and development activities of new drugs as well as treatment options, the rise in government funds for detecting new biomarkers, and the growing incidence of chronic conditions like stroke and cancer.

COMPETITIVE INSIGHTS

The intensity of competitive rivalry within the global multiplex assay market is anticipated to remain high over the projected years. Companies in the market adopt several strategies, including new product developments, mergers and acquisitions, and collaborations, in order to compete and retain their market share. Some of the leading firms operating in the market include F. Hoffmann-la Roche, Agilent Technologies Inc, Qiagen NV, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
- 2.4.1. IMPACT OF COVID-19 ON MULTIPLEX ASSAY MARKET
2.5. MAJOR MARKET FINDINGS
- 2.5.1. SOFTWARE AND SERVICES SECTOR EMERGES AS THE RAPIDLY EXPANDING PRODUCT & SERVICE SEGMENT
- 2.5.2. PROTEIN-BASED MULTIPLEX ASSAY IS THE HIGHEST REVENUE-GENERATING TYPE
- 2.5.3. RESEARCH & DEVELOPMENT APPLICATIONS DOMINATE MARKET SHARE
- 2.5.4. MULTIPLEX PCR TECHNOLOGY DEMONSTRATES FASTER GROWTH
- 2.5.5. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES ARE MAJOR USERS OF MULTIPLEX ASSAYS

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. ESCALATING INCIDENCE OF CHRONIC DISEASES
- 3.1.2. GROWING PREFERENCE FOR MULTIPLEX ASSAYS OVER CONVENTIONAL APPROACHES
- 3.1.3. INCREASING ACCEPTANCE OF PERSONALIZED MEDICINE
3.2. KEY RESTRAINTS
- 3.2.1. OVERCOMING THE DIFFICULTY OF ESTABLISHING A SUFFICIENT ASSAY RANGE
- 3.2.2. CHALLENGES ASSOCIATED WITH CROSS-REACTIVITY AND ASSAY INTERFERENCE
- 3.2.3. SHORTAGE OF SKILLED PROFESSIONALS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
- 4.1.1. RISING DRUG DISCOVERY ENDEAVORS
- 4.1.2. PROGRESS IN ASSAY PLATFORM TECHNOLOGY
- 4.1.3. RAPID EXPANSION OF COMPANION DIAGNOSTICS
4.2. PORTER'S FIVE FORCES MODEL
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
- 4.3.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
- 4.3.2. GROWTH PROSPECT MAPPING FOR GERMANY
- 4.3.3. GROWTH PROSPECT MAPPING FOR INDIA
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS
4.6. KEY BUYING CRITERIA
- 4.6.1. COVERAGE OF ANALYTES
- 4.6.2. RAPIDITY
- 4.6.3. ABILITY TO MULTIPLEX
- 4.6.4. USER-FRIENDLINESS
- 4.6.5. AUTOMATION POTENTIAL
4.7. VALUE CHAIN ANALYSIS
- 4.7.1. RESEARCH AND DEVELOPMENT (R&D)
- 4.7.2. MANUFACTURING AND PRODUCTION
- 4.7.3. DISTRIBUTION AND SUPPLY CHAIN
- 4.7.4. CLINICAL APPLICATION AND DATA ANALYSIS
- 4.7.5. MARKET RESEARCH AND COMMERCIALIZATION

5. MARKET BY PRODUCT AND SERVICE

5.1. REAGENTS AND CONSUMABLES
- 5.1.1. MARKET FORECAST FIGURE
- 5.1.2. SEGMENT ANALYSIS
5.2. INSTRUMENTS AND ACCESSORIES
- 5.2.1. MARKET FORECAST FIGURE
- 5.2.2. SEGMENT ANALYSIS
5.3. SOFTWARE AND SERVICES
- 5.3.1. MARKET FORECAST FIGURE
- 5.3.2. SEGMENT ANALYSIS

6. MARKET BY TYPE

6.1. PROTEIN-BASED MULTIPLEX ASSAY
- 6.1.1. MARKET FORECAST FIGURE
- 6.1.2. SEGMENT ANALYSIS
6.2. NUCLEIC ACID-BASED MULTIPLEX ASSAY
- 6.2.1. MARKET FORECAST FIGURE
- 6.2.2. SEGMENT ANALYSIS
6.3. OTHER TYPES
- 6.3.1. MARKET FORECAST FIGURE
- 6.3.2. SEGMENT ANALYSIS

7. MARKET BY APPLICATION

7.1. RESEARCH AND DEVELOPMENT
- 7.1.1. MARKET FORECAST FIGURE
- 7.1.2. SEGMENT ANALYSIS
7.2. CLINICAL DIAGNOSTICS
- 7.2.1. MARKET FORECAST FIGURE
- 7.2.2. SEGMENT ANALYSIS
7.3. COMPANION DIAGNOSTICS
- 7.3.1. MARKET FORECAST FIGURE
- 7.3.2. SEGMENT ANALYSIS

8. MARKET BY TECHNOLOGY

8.1. MULTIPLEX PROTEIN MICROARRAY
- 8.1.1. MARKET FORECAST FIGURE
- 8.1.2. SEGMENT ANALYSIS
8.2. MULTIPLEX PCR
- 8.2.1. MARKET FORECAST FIGURE
- 8.2.2. SEGMENT ANALYSIS
8.3. OTHER TECHNOLOGIES
- 8.3.1. MARKET FORECAST FIGURE
- 8.3.2. SEGMENT ANALYSIS

9. MARKET BY END-USER

9.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 9.1.1. MARKET FORECAST FIGURE
- 9.1.2. SEGMENT ANALYSIS
9.2. RESEARCH INSTITUTES
- 9.2.1. MARKET FORECAST FIGURE
- 9.2.2. SEGMENT ANALYSIS
9.3. CLINICAL LABORATORIES
- 9.3.1. MARKET FORECAST FIGURE
- 9.3.2. SEGMENT ANALYSIS
9.4. HOSPITALS
- 9.4.1. MARKET FORECAST FIGURE
- 9.4.2. SEGMENT ANALYSIS

10. GEOGRAPHICAL ANALYSIS

10.1. NORTH AMERICA
- 10.1.1. MARKET SIZE & ESTIMATES
- 10.1.2. NORTH AMERICA MULTIPLEX ASSAY MARKET DRIVERS
- 10.1.3. NORTH AMERICA MULTIPLEX ASSAY MARKET CHALLENGES
- 10.1.4. KEY PLAYERS IN NORTH AMERICA MULTIPLEX ASSAY MARKET
- 10.1.5. COUNTRY ANALYSIS
  - 10.1.5.1. UNITED STATES
  - 10.1.5.1.1. UNITED STATES MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
  - 10.1.5.2. CANADA
  - 10.1.5.2.1. CANADA MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
10.2. EUROPE
- 10.2.1. MARKET SIZE & ESTIMATES
- 10.2.2. EUROPE MULTIPLEX ASSAY MARKET DRIVERS
- 10.2.3. EUROPE MULTIPLEX ASSAY MARKET CHALLENGES
- 10.2.4. KEY PLAYERS IN EUROPE MULTIPLEX ASSAY MARKET
- 10.2.5. COUNTRY ANALYSIS
  - 10.2.5.1. GERMANY
  - 10.2.5.1.1. GERMANY MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
  - 10.2.5.2. UNITED KINGDOM
  - 10.2.5.2.1. UNITED KINGDOM MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
  - 10.2.5.3. FRANCE
  - 10.2.5.3.1. FRANCE MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
  - 10.2.5.4. ITALY
  - 10.2.5.4.1. ITALY MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
  - 10.2.5.5. SPAIN
  - 10.2.5.5.1. SPAIN MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
  - 10.2.5.6. BELGIUM
  - 10.2.5.6.1. BELGIUM MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
  - 10.2.5.7. POLAND
  - 10.2.5.7.1. POLAND MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
  - 10.2.5.8. REST OF EUROPE
  - 10.2.5.8.1. REST OF EUROPE MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
10.3. ASIA-PACIFIC
- 10.3.1. MARKET SIZE & ESTIMATES
- 10.3.2. ASIA-PACIFIC MULTIPLEX ASSAY MARKET DRIVERS
- 10.3.3. ASIA-PACIFIC MULTIPLEX ASSAY MARKET CHALLENGES
- 10.3.4. KEY PLAYERS IN ASIA-PACIFIC MULTIPLEX ASSAY MARKET
- 10.3.5. COUNTRY ANALYSIS
  - 10.3.5.1. CHINA
  - 10.3.5.1.1. CHINA MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
  - 10.3.5.2. JAPAN
  - 10.3.5.2.1. JAPAN MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
  - 10.3.5.3. INDIA
  - 10.3.5.3.1. INDIA MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
  - 10.3.5.4. AUSTRALIA & NEW ZEALAND
  - 10.3.5.4.1. AUSTRALIA & NEW ZEALAND MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
  - 10.3.5.5. SOUTH KOREA
  - 10.3.5.5.1. SOUTH KOREA MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
  - 10.3.5.6. THAILAND
  - 10.3.5.6.1. THAILAND MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
  - 10.3.5.7. INDONESIA
  - 10.3.5.7.1. INDONESIA MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
  - 10.3.5.8. VIETNAM
  - 10.3.5.8.1. VIETNAM MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
  - 10.3.5.9. REST OF ASIA-PACIFIC
  - 10.3.5.9.1. REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
10.4. REST OF WORLD
- 10.4.1. MARKET SIZE & ESTIMATES
- 10.4.2. REST OF WORLD MULTIPLEX ASSAY MARKET DRIVERS
- 10.4.3. REST OF WORLD MULTIPLEX ASSAY MARKET CHALLENGES
- 10.4.4. KEY PLAYERS IN REST OF WORLD MULTIPLEX ASSAY MARKET
- 10.4.5. REGIONAL ANALYSIS
  - 10.4.5.1. LATIN AMERICA
  - 10.4.5.1.1. LATIN AMERICA MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES
  - 10.4.5.2. MIDDLE EAST & AFRICA
  - 10.4.5.2.1. MIDDLE EAST & AFRICA MULTIPLEX ASSAY MARKET SIZE & OPPORTUNITIES

11. COMPETITIVE LANDSCAPE

11.1. KEY STRATEGIC DEVELOPMENTS
- 11.1.1. MERGERS & ACQUISITIONS
- 11.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 11.1.3. PARTNERSHIPS & AGREEMENTS
- 11.1.4. BUSINESS EXPANSIONS & DIVESTITURES
11.2. COMPANY PROFILES
- 11.2.1. ABCAM
  - 11.2.1.1. COMPANY OVERVIEW
  - 11.2.1.2. PRODUCT PORTFOLIO
- 11.2.2. AGILENT TECHNOLOGIES INC
  - 11.2.2.1. COMPANY OVERVIEW
  - 11.2.2.2. PRODUCT PORTFOLIO
  - 11.2.2.3. STRENGTHS & CHALLENGES
- 11.2.3. BECTON, DICKINSON AND COMPANY (BD)
  - 11.2.3.1. COMPANY OVERVIEW
  - 11.2.3.2. PRODUCT PORTFOLIO
  - 11.2.3.3. STRENGTHS & CHALLENGES
- 11.2.4. BIO-RAD LABORATORIES INC
  - 11.2.4.1. COMPANY OVERVIEW
  - 11.2.4.2. PRODUCT PORTFOLIO
  - 11.2.4.3. STRENGTHS & CHALLENGES
- 11.2.5. BIO-TECHNE CORPORATION
  - 11.2.5.1. COMPANY OVERVIEW
  - 11.2.5.2. PRODUCT PORTFOLIO
- 11.2.6. CELLCARTA
  - 11.2.6.1. COMPANY OVERVIEW
  - 11.2.6.2. PRODUCT PORTFOLIO
- 11.2.7. F. HOFFMANN-LA ROCHE LTD
  - 11.2.7.1. COMPANY OVERVIEW
  - 11.2.7.2. PRODUCT PORTFOLIO
  - 11.2.7.3. STRENGTHS & CHALLENGES
- 11.2.8. ILLUMINA INC
  - 11.2.8.1. COMPANY OVERVIEW
  - 11.2.8.2. PRODUCT PORTFOLIO
  - 11.2.8.3. STRENGTHS & CHALLENGES
- 11.2.9. MERCK MILLIPORE
  - 11.2.9.1. COMPANY OVERVIEW
  - 11.2.9.2. PRODUCT PORTFOLIO
- 11.2.10. OLINK PROTEOMICS AB
  - 11.2.10.1. COMPANY OVERVIEW
  - 11.2.10.2. PRODUCT PORTFOLIO
- 11.2.11. QIAGEN NV
  - 11.2.11.1. COMPANY OVERVIEW
  - 11.2.11.2. PRODUCT PORTFOLIO
  - 11.2.11.3. STRENGTHS & CHALLENGES
- 11.2.12. RANDOX LABORATORIES LTD
  - 11.2.12.1. COMPANY OVERVIEW
  - 11.2.12.2. PRODUCT PORTFOLIO
- 11.2.13. SEEGENE INC
  - 11.2.13.1. COMPANY OVERVIEW
  - 11.2.13.2. PRODUCT PORTFOLIO
- 11.2.14. SIEMENS HEALTHINEERS AG
  - 11.2.14.1. COMPANY OVERVIEW
  - 11.2.14.2. PRODUCT PORTFOLIO
  - 11.2.14.3. STRENGTHS & CHALLENGES
- 11.2.15. THERMO FISHER SCIENTIFIC INC
  - 11.2.15.1. COMPANY OVERVIEW
  - 11.2.15.2. PRODUCT PORTFOLIO
  - 11.2.15.3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - MULTIPLEX ASSAY
TABLE 2: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: GLOBAL REAGENTS AND CONSUMABLES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: GLOBAL REAGENTS AND CONSUMABLES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: GLOBAL INSTRUMENTS AND ACCESSORIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: GLOBAL INSTRUMENTS AND ACCESSORIES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: GLOBAL SOFTWARE AND SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: GLOBAL SOFTWARE AND SERVICES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: GLOBAL PROTEIN-BASED MULTIPLEX ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: GLOBAL PROTEIN-BASED MULTIPLEX ASSAY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 14: GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 16: GLOBAL OTHER TYPES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: GLOBAL OTHER TYPES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 18: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 19: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 20: GLOBAL RESEARCH AND DEVELOPMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 21: GLOBAL RESEARCH AND DEVELOPMENT MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 22: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 23: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 24: GLOBAL COMPANION DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 25: GLOBAL COMPANION DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 26: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 27: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 28: GLOBAL MULTIPLEX PROTEIN MICROARRAY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 29: GLOBAL MULTIPLEX PROTEIN MICROARRAY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 30: GLOBAL MULTIPLEX PCR MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 31: GLOBAL MULTIPLEX PCR MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 32: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 33: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 34: GLOBAL MULTIPLEX ASSAY MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 35: GLOBAL MULTIPLEX ASSAY MARKET, BY END-USER, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 36: GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 37: GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 38: GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 39: GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 40: GLOBAL CLINICAL LABORATORIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 41: GLOBAL CLINICAL LABORATORIES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 42: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 43: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 44: GLOBAL MULTIPLEX ASSAY MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 45: GLOBAL MULTIPLEX ASSAY MARKET, BY GEOGRAPHY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 46: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 47: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 48: KEY PLAYERS OPERATING IN NORTH AMERICA MULTIPLEX ASSAY MARKET
TABLE 49: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 50: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 51: KEY PLAYERS OPERATING IN EUROPE MULTIPLEX ASSAY MARKET
TABLE 52: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 53: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 54: KEY PLAYERS OPERATING IN ASIA-PACIFIC MULTIPLEX ASSAY MARKET
TABLE 55: REST OF WORLD MULTIPLEX ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 56: REST OF WORLD MULTIPLEX ASSAY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 57: KEY PLAYERS OPERATING IN REST OF WORLD MULTIPLEX ASSAY MARKET
TABLE 58: LIST OF MERGERS & ACQUISITIONS
TABLE 59: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 60: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 61: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES
FIGURE 4: GROWTH PROSPECT MAPPING FOR GERMANY
FIGURE 5: GROWTH PROSPECT MAPPING FOR INDIA
FIGURE 6: MARKET MATURITY ANALYSIS
FIGURE 7: MARKET CONCENTRATION ANALYSIS
FIGURE 8: KEY BUYING CRITERIA
FIGURE 9: VALUE CHAIN ANALYSIS
FIGURE 10: GLOBAL MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY PRODUCT AND SERVICE, IN 2023
FIGURE 11: GLOBAL MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2024-2032 (IN $ MILLION)
FIGURE 12: GLOBAL MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2024-2032 (IN $ MILLION)
FIGURE 13: GLOBAL MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2024-2032 (IN $ MILLION)
FIGURE 14: GLOBAL MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY TYPE, IN 2023
FIGURE 15: GLOBAL MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2024-2032 (IN $ MILLION)
FIGURE 16: GLOBAL MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2024-2032 (IN $ MILLION)
FIGURE 17: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER TYPES, 2024-2032 (IN $ MILLION)
FIGURE 18: GLOBAL MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023
FIGURE 19: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2024-2032 (IN $ MILLION)
FIGURE 20: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2024-2032 (IN $ MILLION)
FIGURE 21: GLOBAL MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2024-2032 (IN $ MILLION)
FIGURE 22: GLOBAL MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2023
FIGURE 23: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2024-2032 (IN $ MILLION)
FIGURE 24: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2024-2032 (IN $ MILLION)
FIGURE 25: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2024-2032 (IN $ MILLION)
FIGURE 26: GLOBAL MULTIPLEX ASSAY MARKET, GROWTH POTENTIAL, BY END-USER, IN 2023
FIGURE 27: GLOBAL MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2024-2032 (IN $ MILLION)
FIGURE 28: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2024-2032 (IN $ MILLION)
FIGURE 29: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2024-2032 (IN $ MILLION)
FIGURE 30: GLOBAL MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)
FIGURE 31: NORTH AMERICA MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 32: UNITED STATES MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 33: CANADA MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 34: EUROPE MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 35: GERMANY MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 36: UNITED KINGDOM MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 37: FRANCE MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 38: ITALY MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 39: SPAIN MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 40: BELGIUM MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 41: POLAND MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 42: REST OF EUROPE MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 43: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 44: CHINA MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 45: JAPAN MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 46: INDIA MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 47: AUSTRALIA & NEW ZEALAND MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 48: SOUTH KOREA MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 49: THAILAND MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 50: INDONESIA MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 51: VIETNAM MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 52: REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 53: REST OF WORLD MULTIPLEX ASSAY MARKET, REGIONAL OUTLOOK, 2023 & 2032 (IN %)
FIGURE 54: LATIN AMERICA MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE 55: MIDDLE EAST & AFRICA MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)